Abstract
Background
Systemic inflammation after augmentation mammaplasty with modern silicone implants is not currently recognized. In a prospective controlled study, C-reactive protein and other variables were monitored, aiming to test this hypothesis in a young cohort of patients.
Methods
Females (18-30 years old, BMI = 18.5-30 kg/m2, N = 52) were consecutively recruited for breast implant (n = 24, Group I) and for abdominal liposuction (n = 28, Group II/Controls). Patients were interviewed at baseline and followed until 6 months after operation. Variables included demographic and clinical information, surgical outcome, inflammatory markers and autoantibodies.
Results
Operations were well tolerated, without surgical or infectious complications. Mean prosthesis size was 258 ± 21 ml (range = 220-280) and mean aspirate of liposuction was 1972 ± 499 ml (range = 1200-3000). Preoperative, 2-month, and 6-month C-reactive protein concentrations for breast implant patients were 1.3 ± 1.2, 4.8 ± 3.0, and 4.3 ± 6.4 mg/l and for liposuction 3.5 ± 2.7, 3.5 ± 2.1, and 2.2 ± 2.2 mg/l, respectively. Change at 2 months was significant (p = 0.001). Autoantibody investigation failed to reveal remarkable aberrations, except for anticardiolipin elevation, which was nearly symmetrical in the two groups.
Conclusion
C-reactive protein levels increased after operation and correlated with proinflammatory and procoagulatory indices. A mild increase in anticardiolipin IgM occurred but differences between populations were lacking. Despite excellent cosmetic outcomes and lack of complications, acute phase reaction could signal ongoing immunogenicity of silicone and long-term monitoring is recommended.
Similar content being viewed by others
References
Noone RB (1997) A review of the possible health implications of silicone breast implants. Cancer 79:1747–1756
Hölmich LR, Vejborg IM, Conrad C, Sletting S, Høier-Madsen M, Fryzek JP, McLaughlin JK, Kjøller K, Wiik A, Friis S (2004) Untreated silicone breast implant rupture. Plast Reconstr Surg 114:204–214
Narins RS, Beer K (2006) Liquid injectable silicone: a review of its history, immunology, technical considerations, complications, and potential. Plast Reconstr Surg 118(3 Suppl):77S–84S
Spear SL, Jespersen MR (2010) Breast implants: saline or silicone? Aesthet Surg J 30:557–570
Bondurant S, Ernster V, Herdman R (eds) (1999) Institute of Medicine (US) Committee on the Safety of Silicone Breast Implants: safety of silicone breast implants. National Academies Press, Washington
Niechajev I, Jurell G, Lohjelm L (2007) Prospective study comparing two brands of cohesive gel breast implants with anatomic shape: 5-year follow-up evaluation. Aesthet Plast Surg 31:697–710
Psillakis JM, Facchina PH, Kharmandayan P, Trillo L, Canzi WC, Aguiar HR (2010) Review of 1,477 breast augmentation payients using PERTHESE silicone implants. Aesthet Plast Surg 34:11–15
Schmidt A, Bengtsson A, Tylman M, Blomqvist L (2007) Pro-inflammatory cytokines in elective flap surgery. J Surg Res 137:117–121
ASAPS (2010) www.surgery.org/sites/default/files/statsquickfacts.pdf. Accessed 27 Dec 2010
Anderson JM, Rodrigues A, Chang DT (2008) Foreign body reaction to biomaterials. Semin Immunol 20:86–100
Wyatt LE, Sinow JD, Wollman JS, Sami DA, Miller TA (1998) The influence of time on human breast capsule histology: smooth and textured silicone-surfaced implants. Plast Reconstr Surg 102:1922–1931
Siggelkow W, Faridi A, Spiritus K, Klinge U, Rath W, Klosterhalfen B (2003) Histological analysis of silicone breast implant capsules and correlation with capsular contracture. Biomaterials 24:1101–1109
Petzold C, Rubert M, Lyngstadaas SP, Ellingsen JE, Monjo M (2011) In vivo performance of titanium implants functionalized with eicosapentaenoic acid and UV irradiation. J Biomed Mater Res A 96:83–92
Bond JS, Duncan JA, Mason T, Sattar A, Boanas A, O’Kane S, Ferguson MW (2008) Scar redness in humans: how long does it persist after incisional and excisional wounding? Plast Reconstr Surg 121:487–496
U.S. FDA (2010) Medical devices, breast implants. Available at www.fda.gov/cdrh/breastimplants/labeling/mentor_patient_labeling_5900.html#9. Accessed 27 Dec 2010
Goncalves WL, Graceli JB, Santos RL, Cicilini MA, Bissoli NS, Abreu GR, Moysés MR (2009) Ultrasound lipoclasia on subcutaneous adipose tissue to produce acute hyperglycemia and enhance acute inflammatory response in healthy female rats. Dermatol Surg 35:1741–1745
Klein S, Fontana L, Young VL, Coggan AR, Kilo C, Patterson BW, Mohammed BS (2004) Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350:2549–2557
Levitsky J, Freifeld A, Lyden E, Stoner J, Florescu D, Langnas A, Brian Stevens R, Hardiman P, Hill L, Kalil AC (2009) Evaluation of the coagulation and inflammatory responses in solid organ transplant recipient and donors. Clin Transplant 23:943–950
Shanklin DR, Smalley DL (1999) Dynamics of wound healing after silicone device implantation. Exp Mol Pathol 67:26–39
Rabelo F, Oliveira CP, Faintuch J, Mazo DF, Lima VM, Stefano JT, Barbeiro HV, Soriano FG, Alves VA, Carrilho FJ (2010) Pro- and anti-inflammatory cytokines in steatosis and steatohepatitis. Obes Surg 20:906–912
Morais AA, Faintuch J, Leal AA, Noe JA, Bertollo DM, Morais RC, Cabrini D (2011) Inflammation and biochemical features of bariatric candidates: does gender matter? Obes Surg 21(1):71–77
Seyhan H, Kopp J, Beier JP, Vogel M, Akkermann O, Kneser U, Schwartz S, Hartmann A, Horch RE (2011) Smooth and textured silicone surfaces of modified gel mammary prostheses cause a different impact on fibroproliferative properties of dermal fibroblasts. J Plast Reconstr Aesthet Surg 64(3):e60–e66
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Silva, M.M., Modolin, M., Faintuch, J. et al. Systemic Inflammatory Reaction After Silicone Breast Implant. Aesth Plast Surg 35, 789–794 (2011). https://doi.org/10.1007/s00266-011-9688-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-011-9688-x